StratDeck

Two stocks in Drug Manufacturers - General

Amgen vs Eli Lilly and Company: profit, growth, debt and price compared

Eli Lilly and Company is stronger on 5 of 7 figures: profit margin, sales growth, debt, analysts' view and price trend. Amgen is stronger on 2: price for its expected profit and dividend.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore Amgen's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Amgen and Eli Lilly and Company side by side
AmgenAMGNEli Lilly and CompanyLLY
Net margin24.1%Stronger: 31.9%
Revenue growth, past year+8.45%Stronger: +38.61%
Debt to equity376.3%Stronger: 122.9%
Forward P/EStronger: 17.7×27.2×
Dividend yieldStronger: 2.27%0.49%
AnalystsHold · 29Stronger: Buy · 29
From its 200-day average+14.8%Stronger: +21.2%

Share price over the past year

  • Amgen+29.0%
  • Eli Lilly and Company+34.2%

18 Nov 202518 Nov 2026

Amgen or Eli Lilly and Company: which is stronger?

  • LLY

    Which is more profitable?

    Eli Lilly and Company keeps more of each sale as profit: 31.9% against 24.1%.

  • LLY

    Which is growing its sales faster?

    Eli Lilly and Company is growing its sales faster: +38.61% over the past year, against +8.45%.

  • LLY

    Which has borrowed less?

    Eli Lilly and Company has borrowed less: its debt is 122.9% of what its shareholders own, against 376.3% for Amgen.

  • AMGN

    Which costs less for the profit it is expected to make?

    Amgen costs less for the profit it is expected to make: 17.7× its forward earnings, against 27.2×.

  • AMGN

    Which pays more in dividends?

    Amgen pays more back in dividends for what a share costs: 2.27% a year, against 0.49%.

  • LLY

    Which do analysts rate higher?

    Analysts are warmer on Eli Lilly and Company: Buy, against Hold for Amgen.

  • LLY

    Which is in the stronger price trend?

    Eli Lilly and Company's price is in the stronger trend: 21.2% above its 200-day average, against 14.8% above.

What each company does

AMGNAmgen

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Reports results on 2 February 2027

LLYEli Lilly and Company

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Reports results on 3 February 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.